RichE posted a post Cornea valuation of MOG from the supporting broker RBS Morgans.
"....Our relative valuation estimate for MOG is unchanged and remains our preferred way to obtain exposure to the Artemis well. We carried no value for Cornea in our MOG valuation estimate, and whilst it may be possible for Cornea to be developed in future, it will require a higher oil price environment. Exposure to the upcoming Braveheart well provides substantial upside exposure for MOG shareholders (> A$0.80/share in an oil success case), albeit high risk...."
